Age and chemotherapy: risk factors versus benefit?

Visit www.ecancer.org for more.
"Age proved to be the most important factor to undergo - or not undergo - chemotherapy," Dr Markopoulos (Athens University Medical School, Athens, Greece) tells ecancertv at SIOG 2014. He discusses the results of a multidisciplinary survey of 900 physicians in 52 countries, examining the interaction between age and breast cancer screening, diagnosis and outcome.
The survey seems to indicate that physicians are more reluctant to prescribe chemotherapy to geriatric patients, and that elderly patients require more proof of benefit.